Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof
申请人:Northeastern University
公开号:US10570146B2
公开(公告)日:2020-02-25
Disclosed are compounds that may be used to inhibit the action of fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL) or dual FAAH/MAGL. More particularly, compounds of formula II
have utility in a variety of therapeutic uses such as treatment of pain, inflammation, neuropathy, or appetite disorder.
本发明公开了可用于抑制脂肪酸酰胺水解酶(FAAH)、单酰甘油脂肪酶(MAGL)或 FAAH/MAGL 双重作用的化合物。更具体地说,式 II 的化合物
具有多种治疗用途,如治疗疼痛、炎症、神经病变或食欲不振。
Cyclohexyl acid triazole azoles as LPA antagonists
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US11319315B2
公开(公告)日:2022-05-03
The present invention provides compounds of Formula (I): Formula (I) or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.